Health Economists Meet the Fourth Tempter: Drog Dependency and Scientific Discourse
Over the past decade, the 'pharmacoeconomics' phenomenon has incited a stream of commentaries about the economic evaluation of drugs, conflicts of interest and ways of retaining respectability for this component of health economics profession. Private coporations now finance so many aspects of health economics, however, that the profession as a whole runs the risk of being co-opted.
To our knowledge, this item is not available for
download. To find whether it is available, there are three
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a search for a similarly titled item that would be available.
|Date of creation:||2000|
|Date of revision:|
|Contact details of provider:|| Postal: |
When requesting a correction, please mention this item's handle: RePEc:fth:brichs:2000:16r. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Thomas Krichel)
If references are entirely missing, you can add them using this form.